This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Chen, N. Articles by Lin, S.-H. Search for Related Content PubMed PubMed Citation Articles by Chen, N. Articles by Lin, S.-H.

A Secreted Isoform of ErbB3 Promotes Osteonectin Expression in Bone and Enhances the Invasiveness of Prostate Cancer Cells

Departments of ¹ Molecular Pathology and ² Genitourinary Medical Oncology, The University of Texas M. D. Anderson Cancer Center; ³ Department of Medicine, Baylor College of Medicine, Houston, Texas; and ⁴ Hope Heart Program, Benaroya Research Institute at Virginia Mason, Seattle, Washington

Requests for reprints: Sue-Hwa Lin, Department of Molecular Pathology, The University of Texas M. D. Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030. Phone: 713-794-1559; Fax: 713-834-6084; E-mail: slin{at}mdanderson.org.

The propensity for prostate cancer to metastasize to bone led us and others to propose that bidirectional interactions between prostate cancer cells and bone are critical for the preferential metastasis of prostate cancer to bone. We identified previously a secreted isoform of ErbB3 (p45-sErbB3) in bone marrow supernatant samples from men with prostate cancer and bone metastasis and showed by immunohistochemical analysis of human tissue specimens that p45-sErbB3 was highly expressed in metastatic prostate cancer cells in bone. Here, we show that p45-sErbB3 stimulated mouse calvaria to secrete factors that increased the invasiveness of prostate cancer cells in a Boyden chamber invasion assay. Using gene array analysis to identify p45-sErbB3–responsive genes, we found that p45-sErbB3 up-regulated the expression of osteonectin/SPARC, biglycan, and type I collagen in calvaria. We further show that recombinant osteonectin increased the invasiveness of PC-3 cells, whereas osteonectin-neutralizing antibodies blocked this p45-sErbB3–induced invasiveness. These results indicate that p45-sErbB3 enhances the invasiveness of PC-3 cells in part by stimulating the secretion of osteonectin by bone. Thus, p45-sErbB3 may mediate the bidirectional interactions between prostate cancer cells and bone via osteonectin. [Cancer Res 2007;67(14):6544–8]

This article has been cited by other articles:

				S. Higgins, S. H. X. Wong, M. Richner, C. L. Rowe, D. F. Newgreen, G. A. Werther, and V. C. Russo Fibroblast Growth Factor 2 Reactivates G1 Checkpoint in SK-N-MC Cells via Regulation of p21, Inhibitor of Differentiation Genes (Id1-3), and Epithelium-Mesenchyme Transition-Like Events Endocrinology, September 1, 2009; 150(9): 4044 - 4055. [Abstract] [Full Text] [PDF]

				P. Gandellini, M. Folini, N. Longoni, M. Pennati, M. Binda, M. Colecchia, R. Salvioni, R. Supino, R. Moretti, P. Limonta, et al. miR-205 Exerts Tumor-Suppressive Functions in Human Prostate through Down-regulation of Protein Kinase C{varepsilon} Cancer Res., March 15, 2009; 69(6): 2287 - 2295. [Abstract] [Full Text] [PDF]

				C. J. Logothetis, N. M. Navone, and S.-H. Lin Understanding the Biology of Bone Metastases: Key to the Effective Treatment of Prostate Cancer Clin. Cancer Res., March 15, 2008; 14(6): 1599 - 1602. [Abstract] [Full Text] [PDF]